Osborn Rohs Williams Donohoe Ltd Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Osborn Rohs Williams Donohoe Ltd reduced its stake in Stryker Corporation by 5.42% during the most recent quarter end. The investment management company now holds a total of 87,267 shares of Stryker Corporation which is valued at $9,924,876 after selling 4,997 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Oct 12, 2016.Stryker Corporation makes up approximately 1.94% of Osborn Rohs Williams Donohoe Ltd’s portfolio.

Other Hedge Funds, Including , Centre Asset Management reduced its stake in SYK by selling 9,110 shares or 7.6% in the most recent quarter. The Hedge Fund company now holds 110,750 shares of SYK which is valued at $13,051,888. Stryker Corporation makes up approx 2.38% of Centre Asset Management’s portfolio.Thompson Rubinstein Investment Management Inc Or reduced its stake in SYK by selling 273 shares or 0.83% in the most recent quarter. The Hedge Fund company now holds 32,667 shares of SYK which is valued at $3,849,806. Stryker Corporation makes up approx 1.47% of Thompson Rubinstein Investment Management Inc Or’s portfolio.Franklin Street Advisors Inc Nc reduced its stake in SYK by selling 620 shares or 18.13% in the most recent quarter. The Hedge Fund company now holds 2,800 shares of SYK which is valued at $326,648. Stryker Corporation makes up approx 0.06% of Franklin Street Advisors Inc Nc’s portfolio.

Stryker Corporation closed down -4.12 points or -3.50% at $113.73 with 14,33,448 shares getting traded on Tuesday. Post opening the session at $117.59, the shares hit an intraday low of $113.14 and an intraday high of $117.68 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.